Intra-tympanic delivery of short interfering RNA into the adult mouse cochlea

Hearing Research

Volumn 296, Issue , 2013, Pages 36-41

  Oishi, Naoki ^a   Chen, Fu Quan ^b   Zheng, Hong Wei ^b   Sha, Su Hua ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; AUDITORY THRESHOLD; COCHLEA; CONTROLLED STUDY; CORTI ORGAN; EARDRUM; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; HEARING IMPAIRMENT; IMMUNOFLUORESCENCE; INTRATYMPANIC DRUG ADMINISTRATION; MALE; MIDDLE EAR; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACOUSTIC STIMULATION; ANIMALS; AUDITORY THRESHOLD; COCHLEA; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EAR, MIDDLE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER TECHNIQUES; HAIR CELLS, AUDITORY; HEARING LOSS, NOISE-INDUCED; INJECTIONS; MALE; MICE; MICE, INBRED CBA; NADPH OXIDASE; NEURONS; NOISE; PUNCTURES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPIRAL GANGLION; TIME FACTORS; TYMPANIC MEMBRANE;

EID: 84870941644     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2012.10.011     Document Type: Article

References (23)

1. Assimakopoulos D., Patrikakos G. Treatment of Meniere's disease by intratympanic gentamicin application. J. Laryngol. Otol. 2003, 117:10-16.
2. Banfi B., Malgrange B., Knisz J., Steger K., Dubois-Dauphin M., Krause K.H. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 2004, 279:46065-46072.
3. Borkholder D.A. State-of-the-art mechanisms of intracochlear drug delivery. Curr. Opin. Otolaryngol. Head Neck Surg. 2008, 16:472-477.
4. Coleman J.K., Littlesunday C., Jackson R., Meyer T. AM-111 protects against permanent hearing loss from impulse noise trauma. Hear. Res. 2007, 226:70-78.
5. Heydt J.L., Cunningham L.L., Rubel E.W., Coltrera M.D. Round window gentamicin application: an inner ear hair cell damage protocol for the mouse. Hear. Res. 2004, 192:65-74.
6. Iwai K., Nakagawa T., Endo T., Matsuoka Y., Kita T., Kim T.S., Tabata Y., Ito J. Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope 2006, 116:529-533.
7. Kaur T., Mukherjea D., Sheehan K., Jajoo S., Rybak L.P., Ramkumar V. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis. 2011, 2:e180.
8. Lee K.Y., Nakagawa T., Okano T., Hori R., Ono K., Tabata Y., Lee S.H., Ito J. Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel. Otol. Neurotol. 2007, 28:976-981.
9. Leidenfrost U. Middle ear deafness and noise trauma: animal studies with the surface specimen technique. Laryngol. Rhinol. Otol. (Stuttg.) 1976, 55:1005-1010.
10. Liu Y., Okada T., Sheykholeslami K., Shimazaki K., Nomoto T., Muramatsu S., Kanazawa T., Takeuchi K., Ajalli R., Mizukami H., Kume A., Ichimura K., Ozawa K. Specific and efficient transduction of Cochlear inner hair cells with recombinant adeno-associated virus type 3 vector. Mol. Ther. 2005, 12:725-733.
11. Maeda Y., Fukushima K., Kawasaki A., Nishizaki K., Smith R.J. Cochlear expression of a dominant-negative GJB2R75W construct delivered through the round window membrane in mice. Neurosci. Res. 2007, 58:250-254.
12. Mikulec A.A., Plontke S.K., Hartsock J.J., Salt A.N. Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol. Neurotol. 2009, 30:131-138.
13. Moneim I.A. Audiometric pattern in a group of workers with one ear conductive deafness exposed to continuous noise. J. Egypt. Public Health Assoc. 1996, 71:243-256.
14. Mukherjea D., Jajoo S., Whitworth C., Bunch J.R., Turner J.G., Rybak L.P., Ramkumar V. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. J. Neurosci. 2008, 28:13056-13065.
15. Mukherjea D., Jajoo S., Kaur T., Sheehan K.E., Ramkumar V., Rybak L.P. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid. Redox Signal. 2010, 13:589-598.
16. Oishi N., Schacht J. Emerging treatments for noise-induced hearing loss. Exp. Opin. Emerg. Drugs 2011, 16:235-245.
17. Plontke S.K., Siedow N., Wegener R., Zenner H.P., Salt A.N. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol. Neurootol. 2007, 12:37-48.
18. Roehm P., Hoffer M., Balaban C.D. Gentamicin uptake in the chinchilla inner ear. Hear. Res. 2007, 230:43-52.
19. Seggas I., Koltsidopoulos P., Bibas A., Tzonou A., Sismanis A. Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol. Neurotol. 2011, 32:29-35.
20. Tamir S., Adelman C., Weinberger J.M., Sohmer H. Uniform comparison of several drugs which provide protection from noise induced hearing loss. J. Occup. Med. Toxicol. 2010, 5:26.
21. Wagner N., Caye-Thomasen P., Laurell G., Bagger-Sjoback D., Thomsen J. Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin. Acta Otolaryngol. 2005, 125:340-345.
22. Wu W.J., Sha S.H., McLaren J.D., Kawamoto K., Raphael Y., Schacht J. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear. Res. 2001, 158:165-178.
23. Xu L., Heldrich J., Wang H., Yamashita T., Miyamoto S., Li A., Uboh C.E., You Y., Bigelow D., Ruckenstein M., O'Malley B., Li D. A controlled and sustained local gentamicin delivery system for inner ear applications. Otol. Neurotol. 2010, 31:1115-1121.